Gamma-glutamyl transpeptidase: redox regulation and drug resistance

MH Hanigan - Advances in cancer research, 2014 - Elsevier
The expression of gamma-glutamyl transpeptidase (GGT) is essential to maintaining
cysteine levels in the body. GGT is a cell surface enzyme that hydrolyzes the gamma …

The dark side of gamma-glutamyltransferase (GGT): Pathogenic effects of an 'antioxidant'enzyme

A Corti, E Belcastro, S Dominici, E Maellaro… - Free Radical Biology …, 2020 - Elsevier
Having long been regarded as just a member in the cellular antioxidant systems, as well as
a clinical biomarker of hepatobiliary diseases and alcohol abuse, gamma …

Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation

AS Mendiola, JK Ryu, S Bardehle, A Meyer-Franke… - Nature …, 2020 - nature.com
Oxidative stress is a central part of innate immune-induced neurodegeneration. However,
the transcriptomic landscape of central nervous system (CNS) innate immune cells …

[HTML][HTML] EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study

V Ratziu, ME Rinella, BA Neuschwander-Tetri… - Journal of …, 2022 - Elsevier
Background & Aims EDP-305 is an oral farnesoid X receptor (FXR) agonist under
development for treating nonalcoholic steatohepatitis (NASH). The efficacy, safety, and …

Targeting gamma-glutamyl transpeptidase: A pleiotropic enzyme involved in glutathione metabolism and in the control of redox homeostasis

A Mitrić, I Castellano - Free Radical Biology and Medicine, 2023 - Elsevier
Gamma-glutamyl transpeptidase (GGT) is an enzyme located on the outer membrane of the
cells where it regulates the metabolism of glutathione (GSH), the most abundant intracellular …

Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH

V Ratziu, SA Harrison, V Loustaud-Ratti, C Bureau… - Journal of …, 2023 - Elsevier
Background & Aims The LIVIFY trial investigated the safety, tolerability, and efficacy of
vonafexor, a second-generation, non-bile acid farnesoid X receptor agonist in patients with …

Prediction of Early Atherosclerotic Plaques Using a Sequence‐Activated Fluorescence Probe for the Simultaneous Detection of γ‐Glutamyl Transpeptidase and …

H Wang, X Zhang, P Li, F Huang, T Xiu… - Angewandte …, 2024 - Wiley Online Library
Atherosclerosis is a lipoprotein‐driven disease, and there is no effective therapy to reverse
atherosclerosis or existing plaques. Therefore, it is urgently necessary to create a …

Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer

C Panis, VJ Victorino, A Herrera, LF Freitas… - Breast cancer research …, 2012 - Springer
Breast cancer is the malignant neoplasia with the highest incidence in women worldwide.
Chronic oxidative stress and inflammation have been indicated as major mediators during …

Red-Emitting Fluorescent Probe for Detection of γ-Glutamyltranspeptidase and Its Application of Real-Time Imaging under Oxidative Stress in Cells and in Vivo

F Liu, Z Wang, W Wang, JG Luo, L Kong - Analytical chemistry, 2018 - ACS Publications
γ-Glutamyltranspeptidase (GGT) plays critical roles in regulating various physiological/
pathophysiological processes including the intracellular redox homeostasis. However, an …

A near-infrared fluorescent probe for evaluating glutamyl transpeptidase fluctuation in idiopathic pulmonary fibrosis cell and mice models

N He, Y Wang, Y Huang, X Wang, L Chen… - Sensors and Actuators B …, 2020 - Elsevier
Idiopathic pulmonary fibrosis (IPF), whose early diagnosis and effective treatment still
remain the focus of clinical studies, is a chronic, irreversible and finally fatal pulmonary …